NovaBridge Biosciences (NBP): Depreciation & Amortization
Older than the company's other figures. The latest Depreciation & Amortization is for the year ended 2023-12-31, while the company's latest annual report covers the year ended 2025-12-31. Its later filings do not report this line under the concept TickerFacts maps.
23.90M CNY
Year ended 2023-12-31
+23.5%
3-year compound annual growth
+29.0%
5-year compound annual growth
| Period ended | Depreciation & Amortization | Change YoY | Source filing |
|---|---|---|---|
| 2023-12-31 | 23.90M CNY | -5.5% | 2024-04-30, From 2023-01-01 |
| 2022-12-31 | 25.30M CNY | +83.3% | 2024-04-30, From 2022-01-01 |
| 2021-12-31 | 13.80M CNY | +8.7% | 2024-04-30, From 2021-01-01 |
| 2020-12-31 | 12.70M CNY | +29.6% | 2023-05-01, From 2020-01-01 |
| 2019-12-31 | 9.80M CNY | +46.3% | 2022-04-29, From 2019-01-01 |
| 2018-12-31 | 6.70M CNY | +318.8% | 2021-04-28, From 2018-01-01 |
| 2017-12-31 | 1.60M CNY | n/a | 2020-04-29, From 2017-01-01 |